BDBM785073 2-((5-bromo-2-((4-(N-(4-(4-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetyl)piperazin-1-yl)butyl)sulfamoyl)-2-methylphenyl)amino)pyrimidin-4-yl)amino)-6-fluorobenzamide::US12466809, Compound 48

SMILES Cc1cc(S(=O)(=O)NCCCCN2CCN(C(=O)COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Br)c(Nc2cccc(F)c2C(N)=O)n1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 785073   

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandChemical structure of BindingDB Monomer ID 785073BDBM785073(2-((5-bromo-2-((4-(N-(4-(4-(2-((2-(2,6-dioxopiperi...)
Ligand Info
In Depth
Date in BDB:
3/2/2026
Entry Details US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandChemical structure of BindingDB Monomer ID 785073BDBM785073(2-((5-bromo-2-((4-(N-(4-(4-(2-((2-(2,6-dioxopiperi...)
Affinity DataIC50: 2.90nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
3/2/2026
Entry Details US Patent